Unibest

Pharmaceutical intermediates

Eslicarbazepine Intermediates

1 pharmaceutical intermediate for Eslicarbazepine. Indication: Seizures.

提交项目All intermediates

About Eslicarbazepine

Originator
Bial-Portela
Indication
Seizures
Approved Date
11/08/2013
DS/DP
05/06/2025

Available intermediates

1 intermediate currently listed for Eslicarbazepine. Request specifications, documentation or a quotation for any item below.

Eslicarbazepine intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
Oxcarbazepine28721-07-5//

Other programs under E

Edoxaban tosylate monohydrateElacestrantElagolix SodiumEldecalcitolElinzanetantElobixibatEltrombopagEltrombopag Olamine

Building toward Eslicarbazepine?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目 联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →